Sartorius Stedim Biotech S.A. (SDMHF)
OTCMKTS · Delayed Price · Currency is USD
210.68
-33.67 (-13.78%)
Jul 22, 2025, 11:08 AM EDT
Sartorius Stedim Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 225.2 | 175.1 | 310.3 | 876.1 | 414.4 | 335.93 | Upgrade |
Depreciation & Amortization | 269.9 | 259.5 | 213.2 | 162.3 | 126.4 | 86.69 | Upgrade |
Other Amortization | 42.2 | 42.2 | 23.6 | 19.4 | 15.2 | 15 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.13 | Upgrade |
Loss (Gain) on Equity Investments | 8.6 | 8.6 | - | - | - | - | Upgrade |
Other Operating Activities | 104.7 | 78.7 | 8.6 | -94.2 | 291.6 | 22.73 | Upgrade |
Change in Accounts Receivable | 3.7 | 38.3 | 162.1 | -65.8 | -87.3 | -73.89 | Upgrade |
Change in Inventory | 75.1 | 207.6 | 131.2 | -217.9 | -275.4 | -116.62 | Upgrade |
Change in Other Net Operating Assets | 58.7 | 5.1 | -102.6 | -67.6 | 217 | 146.91 | Upgrade |
Operating Cash Flow | 788.1 | 815.1 | 746.4 | 612.3 | 701.9 | 416.88 | Upgrade |
Operating Cash Flow Growth | 11.61% | 9.20% | 21.90% | -12.77% | 68.37% | 34.42% | Upgrade |
Capital Expenditures | -291.6 | -339.8 | -473.6 | -430.6 | -324 | -159.19 | Upgrade |
Cash Acquisitions | -1 | - | -2,241 | -515.6 | -141.7 | -470.62 | Upgrade |
Investment in Securities | -0.1 | -0.1 | -8.1 | - | - | - | Upgrade |
Other Investing Activities | -0.1 | -0.1 | -0.1 | -11.3 | 0.5 | 8.69 | Upgrade |
Investing Cash Flow | -292.8 | -340 | -2,723 | -957.5 | -465.2 | -621.12 | Upgrade |
Long-Term Debt Issued | - | 17.3 | 2,649 | 566.8 | 74.2 | 334.79 | Upgrade |
Long-Term Debt Repaid | - | -879.2 | -326.4 | -174.4 | -79.7 | -35.32 | Upgrade |
Net Debt Issued (Repaid) | -36 | -861.9 | 2,323 | 392.4 | -5.5 | 299.47 | Upgrade |
Issuance of Common Stock | 5 | 1,194 | 1.3 | - | - | - | Upgrade |
Repurchase of Common Stock | - | -1.9 | - | -3.2 | - | - | Upgrade |
Common Dividends Paid | -67.1 | -67.1 | -132.7 | -116.1 | -62.7 | -31.34 | Upgrade |
Other Financing Activities | -152 | -177.8 | -205.3 | -52.4 | -9.5 | -34.06 | Upgrade |
Financing Cash Flow | -250.1 | 84.9 | 1,986 | 220.7 | -77.7 | 234.07 | Upgrade |
Foreign Exchange Rate Adjustments | - | 2.3 | -0.3 | 8 | 4.8 | 1.77 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 | Upgrade |
Net Cash Flow | 245.2 | 562.3 | 9.5 | -116.5 | 163.8 | 31.6 | Upgrade |
Free Cash Flow | 496.5 | 475.3 | 272.8 | 181.7 | 377.9 | 257.69 | Upgrade |
Free Cash Flow Growth | 62.79% | 74.23% | 50.14% | -51.92% | 46.65% | 47.96% | Upgrade |
Free Cash Flow Margin | 17.14% | 17.10% | 9.83% | 5.20% | 13.09% | 13.49% | Upgrade |
Free Cash Flow Per Share | 5.10 | 4.91 | 2.96 | 1.97 | 4.10 | 2.79 | Upgrade |
Cash Interest Paid | 176.9 | 176.9 | 116.7 | 10.3 | 8.3 | 8.06 | Upgrade |
Cash Income Tax Paid | 133.5 | 133.5 | 135.8 | 221.2 | 166.6 | 113.98 | Upgrade |
Levered Free Cash Flow | 483.03 | 369.8 | 81.05 | 93.93 | 425.14 | 219.13 | Upgrade |
Unlevered Free Cash Flow | 575.53 | 462.3 | 153.18 | 105.3 | 431.51 | 223.2 | Upgrade |
Change in Net Working Capital | -272.9 | -252.9 | -96.6 | 304.8 | -37.89 | 34.63 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.